Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Evaluation of live attenuated H7N3 and H7N7 vaccine viruses for their receptor binding preferences, immunogenicity in ferrets and cross reactivity to the novel H7N9 virus.

Xu Q, Chen Z, Cheng X, Xu L, Jin H.

PLoS One. 2013 Oct 9;8(10):e76884. doi: 10.1371/journal.pone.0076884. eCollection 2013.

2.
3.

Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.

Chen Z, Baz M, Lu J, Paskel M, Santos C, Subbarao K, Jin H, Matsuoka Y.

J Virol. 2014 Jun;88(12):7016-23. doi: 10.1128/JVI.00100-14. Epub 2014 Apr 9.

4.

Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine.

Carter DM, Bloom CE, Kirchenbaum GA, Tsvetnitsky V, Isakova-Sivak I, Rudenko L, Ross TM.

Vaccine. 2015 Jan 1;33(1):108-16. doi: 10.1016/j.vaccine.2014.11.008. Epub 2014 Nov 18.

PMID:
25448100
5.

Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine.

Babu TM, Levine M, Fitzgerald T, Luke C, Sangster MY, Jin H, Topham D, Katz J, Treanor J, Subbarao K.

Vaccine. 2014 Nov 28;32(50):6798-804. doi: 10.1016/j.vaccine.2014.09.070. Epub 2014 Oct 16.

PMID:
25446831
6.

Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.

Prabakaran M, Kumar SR, Raj KV, Wu X, He F, Zhou J, Kwang J.

Antiviral Res. 2014 Sep;109:149-59. doi: 10.1016/j.antiviral.2014.06.017. Epub 2014 Jul 2.

PMID:
24997413
7.

H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus.

Rudenko L, Isakova-Sivak I, Donina S.

Vaccine. 2013 Oct 1;31(42):4702-5. doi: 10.1016/j.vaccine.2013.08.040. Epub 2013 Aug 26.

PMID:
23988294
8.

Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.

Smith GE, Flyer DC, Raghunandan R, Liu Y, Wei Z, Wu Y, Kpamegan E, Courbron D, Fries LF 3rd, Glenn GM.

Vaccine. 2013 Sep 13;31(40):4305-13. doi: 10.1016/j.vaccine.2013.07.043. Epub 2013 Jul 26.

9.

A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.

Min JY, Vogel L, Matsuoka Y, Lu B, Swayne D, Jin H, Kemble G, Subbarao K.

J Virol. 2010 Nov;84(22):11950-60. doi: 10.1128/JVI.01305-10. Epub 2010 Sep 1.

10.

H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.

Khurana S, Coyle EM, Verma S, King LR, Manischewitz J, Crevar CJ, Carter DM, Ross TM, Golding H.

Vaccine. 2014 Nov 12;32(48):6421-32. doi: 10.1016/j.vaccine.2014.09.049. Epub 2014 Oct 3.

PMID:
25284811
11.

Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.

Jadhao SJ, Achenbach J, Swayne DE, Donis R, Cox N, Matsuoka Y.

Vaccine. 2008 Mar 25;26(14):1742-50. doi: 10.1016/j.vaccine.2008.01.036. Epub 2008 Feb 13.

PMID:
18336962
12.

A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.

Joseph T, McAuliffe J, Lu B, Vogel L, Swayne D, Jin H, Kemble G, Subbarao K.

Virology. 2008 Aug 15;378(1):123-32. doi: 10.1016/j.virol.2008.05.021. Epub 2008 Jun 27.

13.

Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.

Rudenko L, Kiseleva I, Naykhin AN, Erofeeva M, Stukova M, Donina S, Petukhova G, Pisareva M, Krivitskaya V, Grudinin M, Buzitskaya Z, Isakova-Sivak I, Kuznetsova S, Larionova N, Desheva J, Dubrovina I, Nikiforova A, Victor JC, Neuzil K, Flores J, Tsvetnitsky V, Kiselev O.

PLoS One. 2014 Feb 12;9(2):e87962. doi: 10.1371/journal.pone.0087962. eCollection 2014.

14.

H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?

Rudenko L, Isakova-Sivak I, Rekstin A.

Expert Rev Vaccines. 2014 Jan;13(1):1-4. doi: 10.1586/14760584.2014.864564. Epub 2013 Nov 28.

PMID:
24308582
15.

Avian influenza H7N9/13 and H7N7/13: a comparative virulence study in chickens, pigeons, and ferrets.

Kalthoff D, Bogs J, Grund C, Tauscher K, Teifke JP, Starick E, Harder T, Beer M.

J Virol. 2014 Aug;88(16):9153-65. doi: 10.1128/JVI.01241-14. Epub 2014 Jun 4.

16.

Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.

Zhang L, Jia N, Li J, Han Y, Cao W, Wang S, Huang Z, Lu S.

Hum Vaccin Immunother. 2014;10(7):1949-58. doi: 10.4161/hv.28795.

17.

African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.

Matsuoka Y, Suguitan A Jr, Orandle M, Paskel M, Boonnak K, Gardner DJ, Feldmann F, Feldmann H, Marino M, Jin H, Kemble G, Subbarao K.

J Virol. 2014 Jul;88(14):8139-52. doi: 10.1128/JVI.00425-14. Epub 2014 May 7.

18.

Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility.

Belser JA, Blixt O, Chen LM, Pappas C, Maines TR, Van Hoeven N, Donis R, Busch J, McBride R, Paulson JC, Katz JM, Tumpey TM.

Proc Natl Acad Sci U S A. 2008 May 27;105(21):7558-63. doi: 10.1073/pnas.0801259105. Epub 2008 May 27.

19.

Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans.

Overton ET, Goepfert PA, Cunningham P, Carter WA, Horvath J, Young D, Strayer DR.

Vaccine. 2014 Sep 22;32(42):5490-5. doi: 10.1016/j.vaccine.2014.07.078. Epub 2014 Aug 13.

PMID:
25128802
20.

Amino Acid Substitutions Improve the Immunogenicity of H7N7HA Protein and Protect Mice against Lethal H7N7 Viral Challenge.

Kumar SR, Prabakaran M, Ashok Raj KV, He F, Kwang J.

PLoS One. 2015 Jun 1;10(6):e0128940. doi: 10.1371/journal.pone.0128940. eCollection 2015.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk